The use of dextran in the treatment of blood loss and shock.
作者信息
WILSON J S, ESTES E H, DOYLE J T, BLOOM W L, WARREN J V
出版信息
Am J Med Sci. 1952 Apr;223(4):364-9. doi: 10.1097/00000441-195204000-00002.
Abstract
摘要
相似文献
1
The use of dextran in the treatment of blood loss and shock.
Am J Med Sci. 1952 Apr;223(4):364-9. doi: 10.1097/00000441-195204000-00002.
2
[Botulism; dextran and blood transfusion in shock in botulism; brief view and 6 case reports].[肉毒中毒；肉毒中毒休克时的右旋糖酐与输血；简要概述及6例病例报告]
Ugeskr Laeger. 1952 Dec 18;114(51):1817-22.
3
DEXTRAN, plasma volume expander for shock.右旋糖酐，用于休克的血浆容量扩充剂。
Whats New. 1954 Winter;181:5-8.
4
[Pharmacological studies on plasma substitution and shock therapy with dextran].[右旋糖酐用于血浆代用品及休克治疗的药理学研究]
Anaesthesist. 1953 Apr;2(2):71-8.
5
Evaluation of plasma substitutes in clinical shock; dextran.临床休克中血浆代用品的评估；右旋糖酐。
Surg Forum. 1951:631-42.
6
[Value of dextran (makrodeks) in the treatment of shock following surgery, injuries, and burns].[右旋糖酐（大分子右旋糖酐）在治疗手术后、创伤后及烧伤后休克中的价值]
Pol Tyg Lek (Wars). 1955 Jun 13;10(24):793-7.
7
[Use of dextran in prevention and therapy of shock].
Minerva Anestesiol. 1957 Jan;23(1):21-4.
8
Dextran in the treatment of anesthetic shock.右旋糖酐治疗麻醉性休克。
Int J Anesth. 1953;1(2-3):126-7.
9
10
Use of dextran in control of shock resulting from war wounds.右旋糖酐在控制战伤所致休克中的应用。
AMA Arch Surg. 1953 Jun;66(6):730-40. doi: 10.1001/archsurg.1953.01260030750004.
引用本文的文献
1
2
Comparison of hydroxyethyl starch with plasma and dextrans in severe haemodilution.
Can Anaesth Soc J. 1968 Jul;15(4):347-56. doi: 10.1007/BF03006959.
3
Effects of EGF-dextran-tyrosine-131I conjugates on the clonogenic survival of cultured glioma cells.表皮生长因子-葡聚糖-酪氨酸-131I 偶联物对培养的胶质瘤细胞克隆形成存活率的影响。
J Neurooncol. 1992 Nov;14(3):213-23. doi: 10.1007/BF00172597.
4
Enhanced plasma persistence of therapeutic enzymes by coupling to soluble dextran.通过与可溶性葡聚糖偶联提高治疗性酶的血浆持久性。
Biochem J. 1977 May 15;164(2):461-4. doi: 10.1042/bj1640461.
Zotero 插件